tiprankstipranks
Knight Therapeutics (KHTRF)
OTHER OTC:KHTRF
Holding KHTRF?
Track your performance easily

Knight Therapeutics (KHTRF) Financial Statements

33 Followers

Knight Therapeutics Financial Overview

Knight Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.223; its P/E ratio is -16.21; Knight Therapeutics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total RevenueC$ 92.26MC$ 95.57MC$ 86.60MC$ 74.20MC$ 81.50M
Gross ProfitC$ 45.02MC$ 47.34MC$ 41.70MC$ 34.22MC$ 40.18M
EBITC$ 2.52MC$ 3.00MC$ -4.57MC$ -22.06MC$ 11.50M
EBITDAC$ 15.91MC$ 16.17MC$ 8.01MC$ -10.60MC$ 25.20M
Net Income Common StockholdersC$ 85.00KC$ -1.94MC$ -4.55MC$ -24.33MC$ 9.59M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 147.72MC$ 148.84MC$ 174.27MC$ 154.42MC$ 142.46M
Total AssetsC$ 962.29MC$ 945.36MC$ 968.21MC$ 945.49MC$ 1.01B
Total DebtC$ 58.22MC$ 58.11MC$ 70.09MC$ 69.09MC$ 82.02M
Net DebtC$ -89.50MC$ -90.73MC$ -104.18MC$ -85.33MC$ -60.44M
Total LiabilitiesC$ 188.38MC$ 182.56MC$ 206.32MC$ 198.62MC$ 196.48M
Stockholders EquityC$ 773.91MC$ 762.80MC$ 761.89MC$ 746.87MC$ 814.66M
Cash Flow-
Free Cash FlowC$ 2.97MC$ -18.51MC$ 19.95MC$ 18.14MC$ 14.88M
Operating Cash FlowC$ 5.02MC$ -1.09MC$ 30.88MC$ 17.94MC$ 15.17M
Investing Cash FlowC$ 11.53MC$ 11.75MC$ -24.37MC$ -1.90MC$ 35.76M
Financing Cash FlowC$ -3.93MC$ -11.36MC$ -2.90MC$ -35.70MC$ -11.24M
Currency in CAD

Knight Therapeutics Earnings and Revenue History

Knight Therapeutics Debt to Assets

Knight Therapeutics Cash Flow

Knight Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis